Chemical Novelty without Therapeutic Advantage: A Theoretical Account of How Generative Artificial Intelligence Should Reconcile Molecular Originality, Synthetic Accessibility, Selectivity, and Developability in Medicinal Chemistry
Pharmacophore · 2026 · 17 (5) · 1-8
DOI: 10.51847/z45gbppbcs ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacophore, 2026. Verfasst von James Whitfield und 3 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Whitfield, J., Rahman, A., Sato, K., & Lindqvist, S. (2026). Chemical Novelty without Therapeutic Advantage: A Theoretical Account of How Generative Artificial Intelligence Should Reconcile Molecular Originality, Synthetic Accessibility, Selectivity, and Developability in Medicinal Chemistry. Pharmacophore, 17(5), 1-8. https://doi.org/10.51847/z45gbppbcs
Vancouver
Whitfield J, Rahman A, Sato K, Lindqvist S. Chemical Novelty without Therapeutic Advantage: A Theoretical Account of How Generative Artificial Intelligence Should Reconcile Molecular Originality, Synthetic Accessibility, Selectivity, and Developability in Medicinal Chemistry. Pharmacophore. 2026;17(5):1-8. doi:10.51847/z45gbppbcs
BibTeX
@article{Whitfield2026,
author = {Whitfield, James and Rahman, Aisha and Sato, Kenji and Lindqvist, Sofia},
title = {Chemical Novelty without Therapeutic Advantage: A Theoretical Account of How Generative Artificial Intelligence Should Reconcile Molecular Originality, Synthetic Accessibility, Selectivity, and Developability in Medicinal Chemistry},
journal = {Pharmacophore},
year = {2026},
volume = {17},
number = {5},
pages = {1--8},
doi = {10.51847/z45gbppbcs}
}
EUVIMED